Unpublished rating scales: A major source of bias in randomised controlled trials of treatments for schizophrenia

Cited by (870)

Items 801–870 of 870

1. Chlorpromazine versus lithium for people with schizophrenia
   Daniel Cardoso, Katie Tyrrell, Claudia Mancias Guerra, Shareen Rikhraj · 2017 · Cochrane Database of Systematic Reviews
2. Oestrogen (adjunct) versus placebo for women with schizophrenia
   Wan Lian LC Chua, Hristo S Grigorov, John Hiley · 2016 · Cochrane Database of Systematic Reviews
3. Por qué la mayoría de los resultados de investigación publicados son falsos
   John P. A. Ioannidis · 2018 · Revista de Economía Institucional
4. Promoting Financial Management Activities After An Acquired Brain Injury: Enhancing Assessment Evidence
   Lisa Engel · 2018 · TSpace (University of Toronto)
5. Clotiapine for schizophrenia
   Akhil Abhijnhan, Andrea Cipriani, Corrado Barbui · 2007 · Cochrane Database of Systematic Reviews
6. Benzodiazapines for catatonia in persons with schizophrenia and other serious mental illnesses
   RC Gibson, Geoffrey O. Walcott · 2007 · Cochrane Database of Systematic Reviews
7. The Measurement, Treatment and Immunopathology of Leprosy Type 1 Reactions
   Stephen L. Walker · 2010 · LSHTM Research Online (London School of Hygiene and Tropical Medicine)
8. Determining Reliability and Validity of the Modified Gingival Index when Reviewed in an Image-based Survey Format
   Samantha Heron · 2019 · ERA: Education and Research Archive (University of Alberta)
9. Tai Chi plus standard care versus other exercise plus standard care for people with schizophrenia or related disorders
   Jing Li, Jing Shen, Bo Li, Jianlin Wu · 2020 · Cochrane Database of Systematic Reviews
10. Computer-based Cognitive Remediation Therapy plus standard care versus standard care for people with schizophrenia or related disorders
    Santiago Castiello, Miguel Angel Aguayo Mendoza, Javier Ortiz‐Orendain, Israel Itzaman, Édgar Landa-Ramírez, Jaime Carmona, Robin A. Murphy · 2020 · Cochrane Database of Systematic Reviews
11. Collecting subjective and rating scale data within a single case study design: cognitive behavioural therapy for a person experiencing psychosis
    John Arden, Nurse Consultant · 2009
12. Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia
    Adegoke Oloruntoba Adelufosi, Olukayode Abayomi, Tunde Massey-Ferguson Ojo · 2013 · Cochrane Database of Systematic Reviews
13. Reliability, Replicability, and Validity: A Meta-Scientific Analysis
    Kristian E. Markon · 2021
14. Faculty Opinions recommendation of Why most published research findings are false.
    Andreas Wagner · 2005 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
15. Antiglucocorticoid and related treatments for psychosis
    Belinda Garner, Lisa Phillips, Sarah Bendall, Ruth Parslow, Sarah Elisabeth Hetrick · 2008 · Cochrane Database of Systematic Reviews
16. Nicotine for schizophrenia
    Shalet Punnoose, Madhvi R Belgamwar · 2004 · Cochrane Database of Systematic Reviews
17. Pharmacological interventions for reduction of weight gain in people with schizophrenia
    Margaret Hahn, Sri Mahavir Agarwal, Zohra A Ahsan, Jonathan Lockwood, Markus J. Duncan, Hiroyoshi Takeuchi, Tony A. Cohn, Valerie H. Taylor, Gary J. Remington, Guy Faulkner · 2019 · Cochrane Database of Systematic Reviews
18. Validação da versão brasileira da Four Habits Coding Scheme: uma escala para avaliação das habilidades de comunicação de estudantes no encontro clínico
    Renata Rodrigues Catani · 2021
19. Aripiprazole versus sulpiride for people with schizophrenia and schizophrenia-like psychoses
    Jayanti Bhattacharjee, Hany George G El-Sayeh · 2016 · Cochrane Database of Systematic Reviews
20. Methods of Assessing Treatments
    Gary K. K. Lau, Sarah Tamsin Pendlebury, Peter Malcolm Rothwell · 2018 · Cambridge University Press eBooks
21. Penfluridol for schizophrenia
    CJS Ribeiro, MS Lima, BGO Soares · 2001 · Cochrane Database of Systematic Reviews
22. COMMENTARIES
    Sven D' haese · 2003 · European Journal of Oncology Nursing
23. Sultopride for schizophrenia
    Gaby Razzouk, Muhammad Soubhi Azzouz, Kinan Hawasly, Abir Y Koudsi · 2007 · Cochrane Database of Systematic Reviews
24. Anticholinergics for neuroleptic-induced parkinsonism
    Fabio Lawson, Krishma Jethwa, Maurício Silva de Lima, Bernardo GO Soares, Nuwan Galappathie · 2009 · Cochrane Database of Systematic Reviews
25. Cognitive behaviour therapy (brief versus standard duration) for schizophrenia
    Farooq Naeem, Saeed Farooq, David Kingdon · 2013 · Cochrane Database of Systematic Reviews
26. Anticholinergics for neuroleptic-induced parkinsonism
    Fabio Lawson, Krishma Jethwa, Maurício Silva de Lima, Bernardo GO Soares, Nuwan Galappathie · 2006 · Cochrane Database of Systematic Reviews
27. Aripiprazole versus perphenazine for people with schizophrenia and schizophrenia-like psychoses
    Jayanti Bhattacharjee, Hany George G El-Sayeh · 2016 · Cochrane Database of Systematic Reviews
28. Haloperidol versus chlorpromazine for schizophrenia
    C Mentschel, WL Chua, John Michael Kane, Stefan Leucht · 2003 · Cochrane Database of Systematic Reviews
29. Nidotherapy for people with schizophrenia
    Ian J Chamberlain, Stephanie J Sampson · 2012 · Cochrane Database of Systematic Reviews
30. Antipsychotic combinations for schizophrenia
    Christoph Ulrich Correll, Werner Kissling, Christine Rummel‐Kluge, Stefan Leucht · 2009 · Cochrane Database of Systematic Reviews
31. Pericyazine for schizophrenia
    Hosam E. Matar, Muhammad Qutayba Almerie, Samer Makhoul, Pamela Humphreys, Ichiro M Omori · 2008 · Cochrane Database of Systematic Reviews
32. Sultopride for schizophrenia
    Gaby Razzouk, Muhammad Soubhi Azzouz, Kinan Hawasly, Abir Y Koudsi · 2009 · Cochrane Database of Systematic Reviews
33. Different communication strategies for disclosing a diagnosis of schizophrenia and related disorders
    Saeed Farooq, Rupinder K Johal, Farooq Naeem · 2015 · Cochrane Database of Systematic Reviews
34. Monetary incentives for schizophrenia
    Rosanna Michalczuk, Amy Mitchell · 2009 · Cochrane Database of Systematic Reviews
35. Preventive interventions for postnatal psychosis
    Adib Essali, Samer Alabed, Aisha Guul, Norah Essali · 2012 · Cochrane Database of Systematic Reviews
36. Pharmacological interventions for clozapine-induced hypersalivation
    Lorna Duggan, Caroline Cahill, Victor Udu · 2006 · Cochrane Database of Systematic Reviews
37. Antioxidant treatments for schizophrenia
    Pedro Vieira da Silva Magalhães, Ana C. Andreazza, Michael Berk, Flávio Pereira Kapczinski, Olivia May Dean · 2011 · Cochrane Database of Systematic Reviews
38. Behavioural family interventions versus structural family interventions for people with schizophrenia
    Chak Fai Ma, Wai Tong Chien, Sherry Kit Wa Chan, Cho Lee Wong · 2022 · Cochrane Database of Systematic Reviews
39. Clotiapine for schizophrenia
    Akhil Abhijnhan, Andrea Cipriani, Corrado Barbui · 2009 · Cochrane Database of Systematic Reviews
40. Cannabidiol for people with schizophrenia
    Diana Buitrago‐García, Guillermo Sánchez, Paula Alejandra Sánchez Correa, Stela del pilar Baracaldo, Santiago Felipe Gallego Gallego, Lone Baandrup · 2022 · Cochrane Database of Systematic Reviews
41. Nutritional interventions for early psychosis: a systematic review and network meta-analysis
    Yuqing Gao, Yikang Zhu, Jiahui Zeng, Jiayi Ye, Yuchen Zheng, YanYan Wei, Lihua Xu, Andrea Raballo, Chunbo Li, Jijun Wang et al. · 2024 · Cochrane Database of Systematic Reviews
42. Antipsychotics for antipsychotic-naïve people with psychosis
    Hui Wu, Angelika Burschinski, Johannes Schneider‐Thoma, Stefan Leucht, Spyridon Siafis · 2024 · Cochrane Database of Systematic Reviews
43. Psychosocial telemedicine interventions for schizophrenia
    David Kimhy, Luz H. Ospina, Sylvie J Messer, Varuna Sharma, Soumitra Shankar Datta, T. Scott Stroup · 2024 · Cochrane Database of Systematic Reviews
44. MyHealthMyRecord-annotation: An Investigation of Digital Annotation of Short Duration Videos Created to Document a Patient's Health and Well-being
    Sara Mustafa · 2024
45. MyHealthMyRecord-annotation: An Investigation of Digital Annotation of Short Duration Videos Created to Document a Patient's Health and Well-being
    Sara Mustafa · 2024
46. Psychological interventions for early-phase schizophrenia: protocol for a systematic review and network meta-analysis
    Lena Feber, Georgia Salanti, Mathias Harrer, Nurul Husna Salahuddin, Wulf‐Peter Hansen, Josef Priller, Irene Bighelli, Stefan Leucht · 2024 · F1000Research
47. Questionnaires pour l’ORL francophone : recensement et mise au point
    Stéphane Gargula, E. Babin, Maria‐Pia Tuset, Mary Daval, A. Mattei, D. Ayache · 2025 · Annales françaises d Oto-rhino-laryngologie et de Pathologie Cervico-faciale
48. MRI‐Based Evaluation Improves the Validity of Rodent Nerve Regeneration Studies
    Koh Ogawa, Atsushi Mahara, Naoki Morimoto, Tetsuji Yamaoka · 2025 · Advanced Healthcare Materials
49. Additional file 1 of Non-invasive brain stimulation for treatment-resistant schizophrenia: protocol of a systematic review and network meta-analysis
    Spyridon Siafis, Carolin Lorenz, Wu, Hui, Zhu, Yikang, Johannes Schneider‐Thoma, Irene Bighelli, Li, Chunbo, Hansen, Wulf-Peter, Padberg, Frank, Georgia Salanti et al. · 2024 · Figshare
50. Additional file 1 of Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
    Alexander Hodkinson, Heneghan, Carl, Mahtani, Kamal R., Evangelos Kontopantelis, Maria Panagioti · 2021 · Figshare
51. Additional file 4 of Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
    Alexander Hodkinson, Heneghan, Carl, Mahtani, Kamal R., Evangelos Kontopantelis, Maria Panagioti · 2021 · Figshare
52. Additional file 7 of Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
    Alexander Hodkinson, Heneghan, Carl, Mahtani, Kamal R., Evangelos Kontopantelis, Maria Panagioti · 2021 · Figshare
53. Additional file 14 of Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
    Alexander Hodkinson, Heneghan, Carl, Mahtani, Kamal R., Evangelos Kontopantelis, Maria Panagioti · 2021 · Figshare
54. Additional file 13 of Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
    Alexander Hodkinson, Heneghan, Carl, Mahtani, Kamal R., Evangelos Kontopantelis, Maria Panagioti · 2021 · Figshare
55. Additional file 10 of Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
    Alexander Hodkinson, Heneghan, Carl, Mahtani, Kamal R., Evangelos Kontopantelis, Maria Panagioti · 2021 · Figshare
56. Additional file 15 of Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
    Alexander Hodkinson, Heneghan, Carl, Mahtani, Kamal R., Evangelos Kontopantelis, Maria Panagioti · 2021 · Figshare
57. Additional file 5 of Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
    Alexander Hodkinson, Heneghan, Carl, Mahtani, Kamal R., Evangelos Kontopantelis, Maria Panagioti · 2021 · Figshare
58. Additional file 6 of Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
    Alexander Hodkinson, Heneghan, Carl, Mahtani, Kamal R., Evangelos Kontopantelis, Maria Panagioti · 2021 · Figshare
59. Additional file 8 of Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
    Alexander Hodkinson, Heneghan, Carl, Mahtani, Kamal R., Evangelos Kontopantelis, Maria Panagioti · 2021 · Figshare
60. Additional file 9 of Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
    Alexander Hodkinson, Heneghan, Carl, Mahtani, Kamal R., Evangelos Kontopantelis, Maria Panagioti · 2021 · Figshare
61. Additional file 12 of Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
    Alexander Hodkinson, Heneghan, Carl, Mahtani, Kamal R., Evangelos Kontopantelis, Maria Panagioti · 2021 · Figshare
62. Additional file 3 of Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
    Alexander Hodkinson, Heneghan, Carl, Mahtani, Kamal R., Evangelos Kontopantelis, Maria Panagioti · 2021 · Figshare
63. Additional file 2 of Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
    Alexander Hodkinson, Heneghan, Carl, Mahtani, Kamal R., Evangelos Kontopantelis, Maria Panagioti · 2021 · Figshare
64. Additional file 11 of Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
    Alexander Hodkinson, Heneghan, Carl, Mahtani, Kamal R., Evangelos Kontopantelis, Maria Panagioti · 2021 · Figshare
65. Face-to-face psychoeducation for the parents of people with severe mental illness
    Elena Jiménez Tejero, Jesús López‐Alcalde, Ana Carralero Montero, Noelia Álvarez-Díaz, Montserrat García-Sastre, Ángel Luís Asenjo Esteve, Francisco Javier Castro Molina, Alfonso Muriel, Paulina Maravilla Herrera, Diana Monge Martín et al. · 2026 · Cochrane Database of Systematic Reviews
66. Measuring health worker psychological Well-Being: A validation of the WHO-5 Well-Being Index across ten sub-Saharan African countries
    Julia Lohmann, Amanda Cromhout, Arianna Tello Fadda, Lusilda Schutte · 2026 · Wellcome Open Research
67. Mesure de la fragilité chez les personnes âgées vivant à domicile : intérêt et outils
    Nadia Oubaya · 2018 · theses.fr (ABES)
68. Chapter 1. Conceptualization (and Failed Concepts)
    2024 · American Psychiatric Association Publishing eBooks
69. Zuclopenthixol acetate for acute schizophrenia and similar major mental illnesses
    Kaushadh Jayakody, Sarah Chuang, Shalmini Gunadasa, Roger Carl Gibson, Ajit Kumar, Philip Tune · 2026 · Cochrane Database of Systematic Reviews
70. Treatment of transient ischemic attack and stroke
    Sarah Tamsin Pendlebury, Matthew F. Giles, Peter Malcolm Rothwell · 2009 · Cambridge University Press eBooks